REVDOFILIMAB
UNII 2Y83Y2ORD3

Substance Identification & Data

This profile provides standardized clinical and technical data for Revdofilimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2Y83Y2ORD3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2230138-89-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
2Y83Y2ORD3
CAS Registry Number
2230138-89-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
REVDOFILIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11242
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Revdofilimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

REVDOFILIMAB

Common Names & Synonyms

ABBV-368 (HUMANIZED, RECOMBINANT MONOCLONAL ANTIBODY THAT BINDS TO CELL SURFACE EXPRESSED OX40 (TNF RECEPTOR SUPERFAMILY MEMBER 4))
ANTI-OX40 AGONIST MONOCLONAL ANTIBODY ABBV-368
MAB HUMANIZED (IGG1) ANTI P43489 (TNR4_HUMAN) (ABBV368)
REVDOFILIMAB [INN]
REVDOFILIMAB [WHO-DD]

Technical Codes

ABBV368
ABBV-368
PR1628103
PR-1628103